Literature DB >> 33563925

The role of noncoding RNAs in epithelial cancer.

Massimiliano Agostini1, Carlo Ganini2, Eleonora Candi3,4, Gerry Melino5,6.   

Abstract

Regulatory noncoding RNAs (ncRNAs) are a class of RNAs transcribed by regions of the human genome that do not encode for proteins. The three main members of this class, named microRNA, long noncoding RNA, and circular RNA play a key role in the regulation of gene expression, eventually shaping critical cellular processes. Compelling experimental evidence shows that ncRNAs function either as tumor suppressors or oncogenes by participating in the regulation of one or several cancer hallmarks, including evading cell death, and their expression is frequently deregulated during cancer onset, progression, and dissemination. More recently, preclinical and clinical studies indicate that ncRNAs are potential biomarkers for monitoring cancer progression, relapse, and response to cancer therapy. Here, we will discuss the role of noncoding RNAs in regulating cancer cell death, focusing on those ncRNAs with a potential clinical relevance.

Year:  2020        PMID: 33563925     DOI: 10.1038/s41420-020-0247-6

Source DB:  PubMed          Journal:  Cell Death Discov        ISSN: 2058-7716


  137 in total

Review 1.  Non-apoptotic functions of BCL-2 family proteins.

Authors:  Atan Gross; Samuel G Katz
Journal:  Cell Death Differ       Date:  2017-02-24       Impact factor: 15.828

Review 2.  How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?

Authors:  Brandon J Aubrey; Gemma L Kelly; Ana Janic; Marco J Herold; Andreas Strasser
Journal:  Cell Death Differ       Date:  2017-11-17       Impact factor: 15.828

3.  [Cancer developed on idiopathic megaesophagus].

Authors:  C Debray; J Leymarios; J P Etienne; J P Cuq
Journal:  Arch Fr Mal App Dig       Date:  1968 Jan-Feb

Review 4.  Deconstructing networks of p53-mediated tumor suppression in vivo.

Authors:  Alyssa M Kaiser; Laura D Attardi
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

Review 5.  Viewing BCL2 and cell death control from an evolutionary perspective.

Authors:  Andreas Strasser; David L Vaux
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

6.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

Authors:  Y Tsujimoto; L R Finger; J Yunis; P C Nowell; C M Croce
Journal:  Science       Date:  1984-11-30       Impact factor: 47.728

Review 7.  Why are there hotspot mutations in the TP53 gene in human cancers?

Authors:  Evan H Baugh; Hua Ke; Arnold J Levine; Richard A Bonneau; Chang S Chan
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

Review 8.  The interplay between mutant p53 and the mevalonate pathway.

Authors:  Alejandro Parrales; Elizabeth Thoenen; Tomoo Iwakuma
Journal:  Cell Death Differ       Date:  2017-12-13       Impact factor: 15.828

Review 9.  p53 on the crossroad between regeneration and cancer.

Authors:  Meital Charni; Ronit Aloni-Grinstein; Alina Molchadsky; Varda Rotter
Journal:  Cell Death Differ       Date:  2016-10-21       Impact factor: 15.828

Review 10.  Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism.

Authors:  Alice Nemajerova; Ivano Amelio; Jakob Gebel; Volker Dötsch; Gerry Melino; Ute M Moll
Journal:  Cell Death Differ       Date:  2017-10-27       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.